Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: Am J Clin Oncol. 2017 Oct;40(5):470–476. doi: 10.1097/COC.0000000000000188

Table Ib.

Baseline Characteristics of Stage IV Non-small Cell Lung Cancer Patients According to Treatment Received

Characteristic Untreated
(N=8,169)
Chemotherapy
(N=6,634)
P-value
Age (median, IQR) 78 (8) 75 (7) <0.0001
Female, N (%) 3,689 (45.2) 2,895 (43.6) 0.06
Married, N (%) 3,928 (48.1) 3,967 (59.8) <0.0001
Race/Ethnicity, N (%)
 White 6,464 (79.1) 5,647 (85.1) <0.0001
 Black 822 (10.1) 437 (6.6)
 Hispanic 341 (4.2) 217 (3.3)
 Other 542 (6.6) 333 (5.0)
Median Annual Neighborhood Income, N(%)
 First Quartile* 2,281 (27.9) 1,491 (22.5) <0.0001
 Second Quartile 2,022 (24.8) 1,594 (24.1)
 Third Quartile 1,946 (23.8) 1,641 (24.8)
 Fourth Quartile 1,917 (23.5) 1,903 (28.7)
Comorbidity Score, N (%)
 <1 3,021 (37.0) 3,036 (45.8) <0.0001
 1–2 1,964 (24.0) 1,745 (26.3)
 >2 3,184 (39.0) 1,853 (27.9)
Histology, N (%)
 Adenocarcinoma 4,459 (54.6) 4,008 (60.4) <0.0001
 Squamous Cell 2,198 (5.7) 1,593 (24.0)
 Large Cell 464 (5.7) 406 (6.1)
 Other 1,048 (12.8) 627 (9.5)
Tumor Site, N (%)
 Upper 3,358 (41.1) 2,946 (44.4) <0.0001
 Middle 310 (3.8) 257 (3.9)
 Lower 2,050 (25.1) 1,695 (25.6)
 Unknown 2,451 (30.0) 1,736 (26.2)
*

Indicate lowest income quartile